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Several reports have documented adenocarcinoma arising from endometriotic 
implants within the cesarean section (C-S) scar on the serosal surface of the uterus.  
However, endometrial cancer invading the C-S scar from the uterine cavity has not been 
described.  We report a case of a grade-1 endometrioid adenocarcinoma “drop” lesion 
invading a previous C-S scar with resultant cervical stromal invasion.  Using both MR 
images and a thorough review of the pathology, the tumor at the C-S scar was 
determined to be an implant derived from a primary lesion at the uterine fundus.  With 
increases in the incidence of both endometrial cancer and births by C-S, it is likely we 
will encounter more cases of iatrogenic implants of endometrial cancers in C-S scars. 
 





Uterine corpus cancer is the leading cause of malignant gynecological disease 
with more than 40,000 cases diagnosed per year in the US and the number of patients 
bearing this disease steadily increasing1.  In Japan, the incidence has been increasing 
and is predicted to be the leading cause of gynecological malignancy in the next decade. 
Placental attachment to the cesarean section (C-S) scar is observed in 20% of 
placenta previas, and placenta previa-accreta occurs 3-14 times more frequently in 
women who have had a C-S compared to those not2. This suggests that the C-S scar is 
more prone to trophoblastic invasion and has a susceptibility to tumor invasion as well.   
While there are reports of both endometrioid and clear cell adenocarcinomas 
arising from endometriotic implants within the C-S scar on the peritoneal surface of the 
uterus3, 4, ours is the first of an endometrial cancer “drop” lesion invading a C-S scar 
with the primary lesion being a small lesion at the uterine fundus.  As the C-S rate has 
increased from 21% to 31% over the last decade5, we are likely to encounter 
endometrial cancers invading C-S scars more frequently.  This may require new 
therapeutic strategies to address this specific scenario. 
 
CASE 
A 43- year-old obese (BMI 30) postmenopausal woman (gravida 1, para 1) 
presented to our hospital because of intermittent abnormal vaginal bleeding lasting for 
one month.  Her obstetrical history was significant for cesarean delivery of a 3400g 
male baby via a low transverse uterine incision due to labor dystocia at 29 years of age.    
Physical exam showed a small amount of bloody discharge from the uterus and an 8-10 
week size uterus.  Ultrasonography demonstrated a 3 cm hyperechoic intrauterine 
lesion at the uterine isthmus and endometrial biopsy was positive for adenocarcinoma.  
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Subsequent hysteroscopy revealed a protruding tumor with atypical vessels in the 
cervical canal and diffuse papillary tumor mainly covering the left-anterior wall just 
above the internal os. Thorough exploration inside of uterus was prevented by the 
massive growth of this tumor. Endometrial curettings demonstrated a grade 1 
endometrioid adnocarcinoma.  Serum CA125 level was elevated to 64.8 U/ml (normal 
range <35), while CEA 0.8 ng/ml (<2.5) and CA19-9 36.8 U/ml (<37) were within 
normal range.  
Sagittal T-2 weighted magnetic resonance (MR) images demonstrated a thin 
low anterior uterine wall and bulging of the endometrial cavity at the uterine isthmus 
(Figure 1A).  A T-2 low intensity lesion was observed to occupy this bulging from the 
lower uterine cavity to the cervical canal and suggested myometrial invasion (Figure 
1B).  However, on the T1-weighted dynamic images (Figure 1C), the border between 
the tumor and the myometrium was smooth and the contrast enhancement of the isthmic 
tumor was poor which suggested the myometrial invasion was superficial.  In addition 
to the isthmic lesion, a small intrauterine polypoid low intensity lesion was detected at 
the uterine fundus (Figure 1A).  Computed tomography did not describe any 
lymphadenopathy or extrauterine metastases. 
 
The patient underwent a modified radical hysterectomy, bilateral 
salpingo-oophorectomy, and pelvic and paraaortic lymphadenectomy. As intraoperative 
peritoneal cytology was positive, partial omentectomy was performed although there 
was no gross evidence of dissemination or metastasis at the time of surgery. 
On gross examination, the uterus was enlarged (Figure 2A), and the tumor 
measured 55mm x 50mm and was located predominantly in the uterine isthmus with a 
portion of the tumor encroaching the cervix (Figure 2B).  There were also polypoid 
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tumors protruding into the endometrial cavity at the uterine fundus (Figure 2C).  The 
fundal and isthmic lesions were separate and the endometrial surface between these 
tumor sites was obviously smooth and tumor-free.  On the cut surface, the tumor was 
yellowish to whitish in color, and the isthmic tumor appeared to invade the uterine 
myometrium at the site of the cesarean scar, while the fundal tumor showed no invasive 
features. 
Microscopically, a well-differentiated grade-1 endometrioid adenocarcinoma 
was identified in both the fundal (Figure 3A) and isthmic (Figure 3B) tumors.  The 
fundal tumor was observed adjacent to normal secretory phase endometrium and 
endometrial hyperplasia but no myometrial invasion or desmoplastic stromal reaction 
was detected (Figure 3C).  In contrast, the endometrium at the C-S scar was very thin 
and composed only of a single-layer of epithelial cells without normal endometrial 
stromal cells (Figure 3D).  The isthmic tumor invaded the myometrium at the C-S 
section site, but also lacked a desmoplastic stromal reaction, giving the impression that 
the tumor did not originate at this site but was an implant from another source.  
Additionally, the tumor implant encroached the upper wall of the cervix (Figure 3E) and 
demonstrated lymphovascular space involvement (Figure 3F). Lymph node metastasis 
was not observed, and the tumor was designated as pT3aN0M0. Adjuvant chemotherapy 
with cisplatin and adriamycin was employed and there has been no recurrence to date. 
  
DISCUSSION 
We report a case of endometrial carcinoma in which a cancer lesion existed 
both in the endometrial fundus and the C-S scar in the isthmus independently. The 
pathological features of both tumors were similar, although these were separate and had 
no direct connection to one another.  There are theoretically three possibilities as 
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regards to the origin of these two lesions: 1) both are synchronous primary tumors, 2) 
the tumor at the C-S scar is the primary tumor with the fundal lesion a metastatic 
implant, or our strongest suspicion, 3) the fundal tumor is the primary tumor with a 
metastatic lesion to the C-S scar. We speculate that this grade-1 endometrioid 
adenocarcinoma arose from the endometrium at the uterine fundus and then “dropped 
down” to the isthmus as an implant on the C-S scar. Our assumption is based on these 
findings:1) pathologically, the lesion in the endometrium appeared to be primary since it 
was accompanied with endometrial hyperplasia in a thickened normal endometrium, 2) 
the C-S scar was only covered with a single layer of epithelium and could not be 
regarded as the tumor origin, and 3) the C-S scar can be regarded as “seed-soil” for 
tumor implantation.  C-S scar site is reported in a hypermetabolic condition 6 showing 
neoangiogenesis with remarkable VEGF expression7, although it is not confirmed such 
state will be kept for long.  However, recurrence of endometrial cancers due to 
“seeding” during primary surgery has been actually reported in a laparotomy incision8, a 
laparoscopy-trocar site9 , and within the scar following the marsupialization of a benign 
Bartholin’s cyst10-- each of these suggesting that the surgical scar can serve as an 
iatrogenic receptor for endometrial cancer implants. Scar endometriosis in the peritoneal 
cavity is infamous as an iatrogenic precursor of several malignant transformations3, 4, 11.  
Although our case differs in that there was no pathological evidence of endometriosis, 
C-S scar inside of uterus should be regarded as another site of cancer involvement. 
Although the International Federation of Obstetricians and Gynecologists 
(FIGO) staging of uterine corpus is designed to reflect tumor biology and patterns of 
spread, a variety of risk factors besides FIGO staging system have been demonstrated, 
such as pathological grade, depth of myometrial invasion, and lymphovascular space 
involvement (LVSI).  Endometrial cancer arising in the uterine isthmus (UIE), which 
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accounts for only 3-4% of uterine cancers, is a unique form with a poor prognosis 
compared with those arising in the middle or upper parts of the uterine corpus (UCE) 12.  
When compared to UCE, UIE is more frequently associated with high risk factors: 
deep-myometrial invasion (38.5% vs 12.1%), positive peritoneal cytology (38.5% vs 
15.2%), and LVSI (46.2% vs 21.2%)12.  LVSI is an independent risk factor of 
endometrial cancers for metastasis and relapse13, and direct invasion of the upper 
cervical wall is significantly correlated with LVSI 14.  In this case, although primary 
lesion of the fundus was minimal, tumor showed unfavorable features to involve the 
cervix and lymphatic flows, possibly because of the presence of the C-S scar. 
It is well-known that placenta accreta-previa occurs in the C-S scar in up to 
14% of C-S, while it occurs only in 1-5% in the intact uterus2, suggesting that the C-S 
scar may be a susceptible site for myometrial invasion.  Our report suggests that the 
C-S scar may also share the propensity for myometrial invasion with endometrial 
cancers and may facilitate cervical invasion and/or LVSI even when the grade of the 
tumor lacks aggressive features.  Cervical invasion of endometrial cancer cannot be 
clinically ignored as the 5-year survival rate of stage II endometrial cancer is 78.3%, 
much less than the 89.6% of patients with stage I disease (Hazard ratio; 2.2)15.  These 
results may evoke a need to perform a conventional or modified radical hysterectomy in 
cases with C-S scar involvement, for regarding the subsequent invasion into 
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Figure 1. Magnetic Resonance Imaging of this case.  
Sagittal section (A) and axial section (B) of T2-weighed images: A low intensity lesion 
occupies the lower uterine cavity. Sagittal section of T1-weighed dynamic images (C): 
the border between the tumor and the endometrium is smooth. 
 
Figure 2. Polypoid tumor growth at uterine isthmus and fundus.  
Gross appearance (A). C-S scar stenosis was observed at uterine isthmus. Papillary 
tumor was predominantly located around this scar (B). Polypoid tumor protruded from 
the uterine fudus (C).  
 
Figure 3. Microscopic findings of well differentiated endometrioid adenocarcinoma 
at uterine fundus (A) and isthmus (B).  
Grade-1 endometrioid adenocarcinoma next to the normal thickened endometrium (A) 
lacked a prominent myometrial invasion (C). Grade-1 endometrioid adenocarcinoma 
adjacent to the single layered endometrial cells at the C-S scar (D). Encroaching growth 
toward uterine cervix (E) and lymphovascular space involvement (F) of isthmus tumor. 
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